FRANKFURT (dpa-AFX) - The Redcare Pharmacy share remained under pressure on Thursday. At lunchtime, it was at the bottom of the MDax, losing 3.8 percent to 125.70 euros. At times it had slumped even lower, approaching the interim low of 122.65 euros reached on December 22. The 50-day moving line at around 125.50 euros still represents support.

The day before, the online pharmacy's shares had already lost almost ten percent despite the presentation of surprisingly strong quarterly figures. The trigger was a downgrade by Warburg Research. Analyst Michael Heider had referred to the massive rise in the share price over the past twelve months. He therefore no longer sees any new price drivers for the time being, even though, according to him, Redcare is the best-positioned online pharmacy in Europe and is gaining market share.

Hamburg-based analyst firm Alsterresearch also downgraded the Redcare share from "Hold" to "Sell" on Wednesday following the presentation of the figures. Analyst Thomas Wissler expressed concerns about a slowdown in growth under the company's own steam. He left his target price unchanged at 120 euros./ck/nas/mis